John Ballantyne
About John Ballantyne
Title and Current Roles
John Ballantyne holds the title of Director. He is the founder of Agathos Biologics and a partner in the Kineticos Disruptor Fund. These roles demonstrate his active involvement and leadership in the biotechnological and pharmaceutical sectors.
Founding of Agathos Biologics
John Ballantyne founded Agathos Biologics, a company dedicated to the advancement of biotechnology. His leadership in founding and directing the company highlights his ongoing commitment to innovation and development in biological sciences.
Co-founder of Aldevron
John Ballantyne co-founded Aldevron in 1998, a significant milestone in his career. Aldevron is known for its contributions to the biotechnology field, particularly in the production of plasmid DNA, proteins, and other biological material.
Chief Scientific Officer at Aldevron
John Ballantyne served as the Chief Scientific Officer at Aldevron until the end of 2021. In this role, he was responsible for overseeing the scientific direction and research activities of the company, contributing to its growth and success.
Educational Background
John Ballantyne received his undergraduate degrees in Pharmacy from the Central Institute of Technology and the University of Otago in New Zealand. He later completed a Ph.D. in Pharmaceutical Sciences at North Dakota State University. He transferred to the United States in 1994 to pursue his graduate studies.